Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cell component proteins encompass a vast and diverse array of proteins essential for the survival, structure, and replication of bacterial pathogens. This broad category includes enzymes involved in metabolic pathways, structural proteins that maintain the integrity of the cell wall and membranes, and machinery responsible for genetic expression and protein synthesis (e.g., RNA polymerase and ribosomal proteins). Because many of these proteins are highly conserved within bacteria but distinct from their eukaryotic counterparts, they serve as the primary targets for the majority of clinical antibiotics. For instance, penicillin-binding proteins (PBPs) are essential for peptidoglycan cross-linking in the cell wall, while the 30S and 50S ribosomal subunits are targeted by aminoglycosides and macrolides to halt protein production. In the context of infectious diseases, these proteins are critical for pathogenesis and are the focus of both therapeutic intervention and vaccine development. However, the term is considered 'incorrect' as a specific therapeutic target because it is a collective grouping rather than a single, defined molecular entity.
Inhibition of cell wall peptidoglycan synthesis, binding to 30S or 50S ribosomal subunits to inhibit translation, inhibition of DNA gyrase/topoisomerase, or inhibition of RNA polymerase.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell component proteins.